The dimerization of ALK mediated by its fusion partner results in a constitutive activation of the ALK tyrosine kinase activity and subsequently mediates an increase in pro-growth and anti-apoptotic signaling in NSCLC (33, 34). The gene discussed is ALK; the disease is non-small cell lung carcinoma.